Replies to post #730095 on NorthWest Biotherapeutics Inc (NWBO)

[meirluc]

I disagree JT because the success of the treatment in the UK
will receive a lot of publicity and soon thereafter the potential
of this treatment in other countries and for other types of cancer
will also become well known. I am almost certain that if the FDA still
finds excuses for not accepting NWBO's BLAs, American neurologists will
express their outrage. The last thing that the FDA would wish for is a flood
of criticism from American cancer patients and the American medical community.

I am therefore betting on submission of a BLA to the FDA sometime during 2025.